Gotham Asset Management, LLC - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 246 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
Gotham Asset Management, LLC ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$483,217
-0.4%
17,736
-18.6%
0.01%
-9.1%
Q2 2023$485,095
-23.3%
21,802
-25.4%
0.01%
-26.7%
Q1 2023$632,624
-28.7%
29,207
-33.1%
0.02%
-40.0%
Q4 2022$886,836
-9.3%
43,665
+14.4%
0.02%
-13.8%
Q3 2022$978,000
-13.1%
38,155
-19.4%
0.03%
-19.4%
Q2 2022$1,125,000
+1.1%
47,321
-4.3%
0.04%
+5.9%
Q1 2022$1,113,000
+15.1%
49,440
+1.2%
0.03%
+9.7%
Q4 2021$967,000
+164.9%
48,846
+163.1%
0.03%
+106.7%
Q3 2021$365,000
+8.0%
18,567
+20.7%
0.02%
+7.1%
Q2 2021$338,000
-15.3%
15,379
-8.2%
0.01%
-22.2%
Q1 2021$399,000
-42.6%
16,752
-36.9%
0.02%
-21.7%
Q4 2020$695,000
-7.9%
26,563
-38.8%
0.02%
-4.2%
Q3 2020$755,000
+54.7%
43,385
+49.5%
0.02%
+60.0%
Q2 2020$488,000
-43.3%
29,011
-59.9%
0.02%
-37.5%
Q1 2020$860,000
-9.0%
72,343
-7.4%
0.02%
+41.2%
Q4 2019$945,000
+38.0%
78,134
+61.2%
0.02%
+41.7%
Q3 2019$685,000
-19.3%
48,460
-36.4%
0.01%
-14.3%
Q2 2019$849,000
-37.6%
76,187
-34.2%
0.01%
-30.0%
Q1 2019$1,360,000
-17.1%
115,829
-5.7%
0.02%
-23.1%
Q4 2018$1,641,000
+108.0%
122,793
+118.3%
0.03%
+136.4%
Q3 2018$789,000
-28.3%
56,260
-19.7%
0.01%
-31.2%
Q2 2018$1,101,000
+222.9%
70,021
+238.1%
0.02%
+220.0%
Q1 2018$341,000
+5.9%
20,712
+16.1%
0.01%0.0%
Q4 2017$322,000
-74.9%
17,834
-73.2%
0.01%
-73.7%
Q3 2017$1,282,000
+82.1%
66,450
+11.4%
0.02%
+90.0%
Q2 2017$704,000
+450.0%
59,657
+410.4%
0.01%
+400.0%
Q1 2017$128,000
-53.6%
11,689
-69.2%
0.00%
-50.0%
Q4 2016$276,000
+102.9%
38,010
+81.8%
0.00%
+100.0%
Q3 2016$136,000
+65.9%
20,908
+39.2%
0.00%
+100.0%
Q2 2016$82,000
-4.7%
15,024
-13.4%
0.00%0.0%
Q4 2015$86,000
+32.3%
17,347
+0.7%
0.00%0.0%
Q3 2015$65,00017,2210.00%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,370,017$181,2959.31%
Novo Holdings A/S 3,377,768$73,162,4554.83%
Parallel Advisors, LLC 3,724,573$80,674,2512.72%
TANAKA CAPITAL MANAGEMENT INC 35,539$7702.24%
Shay Capital LLC 350,000$7,581,0001.49%
Shay Capital LLC 350,000$7,581,0001.49%
S&T BANK/PA 350,924$7,6011.37%
Birchview Capital, LP 50,000$1,0830.85%
Clearview Wealth Advisors LLC 34,275$742,3970.75%
Granite Investment Partners, LLC 795,076$17,221,3460.72%
View complete list of CORCEPT THERAPEUTICS INC shareholders